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Abstract
           Pentagamavunon-1 (PGV-1) is a curcumin analogue, which is more stable in organic solution and more
rigid in its chemical structure than curcumin. As a curcumin analogue, PGV-1 was considered to have anticancer
activities. This research was conducted to study the effect of PGV-1 on the cycle progression of T47D cells. Cyto-
toxic effects of PGV-1 on T47D cells were determined using MTT assay, and the the effect on cell cycle progression
was carried out using flowcytometry. Western blot analysis was used to analyze protein expression correspond-
ing to cell cycle progression. The result showed that at the concentration of 2.5 µM PGV-1 inhibited cell cycle
progression through G2/M arrest and induced of cells hyperploidy formation. The hyperploidy formation in-
duced by PGV-1 was related to the increase of cdc-2 expression. PGV-1 2.5 µM elevated the level of p21 CIP/KIP
through p53- independent manner. Apoptosis was also induced by PGV-1 at early phase of treatment indicated by
PARP cleavage due to activation of caspase-3/7 after 12 h treatment. The results above suggest that PGV-1 inhibits
the growth of T47D cells targeted on microtubules.
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Introduction
Curcumin (Figure 1) is a β-diketone
constituent of turmeric obtained from the
powdered root of Curcuma longa, Linn.
Curcumin performed  anti-cancer proper-
ties  through cell growth inhibition and
apoptosis induction. Curcumin inhibit cell
proliferation by inducing a growth arrest in
the G2/M phase on breast cancer cell line,
as well as in other stages (Mehta et al., 1997;
Ramachandran and You, 1999, Simon et al.,
1990, Choudury et al., 1999). Arresting cells
at G2/M phase by curcumin is coused by
the mitotic spindle checkpoint (Holy et al.,
2002).
Curcumin is unstable at pH above 6.5
and on the presence of light (Tonnesen and
Karlsen, 1995; van der Goot, 1997). The in-
stability is attributed to the active methyl-
ene group. Omission of this group results in
the more stabile curcumin analogue. A pre-
liminary pharmacophore model divided
curcumin into three regions (Robinson,
2003). Region A requires an aromatic ring,
region B is composed of a symmetrical
diendione linker, and region C also requires
an aromatic ring (Figure 1). Examination of
curcumin suggested that the two aromatic
regions might be critical for potential ligand-
receptor binding. A reasonable approach
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was to explore compounds with differences
in the carbon chain connecting of the aro-
matics region. Pentagamavunon-1 (2,5-bis-
(4’-hydroxy-3’,5’-dimethyl)-benzillidine-
siclopentanone, known as PGV-1, Figure 1),
which has been developed and patented by
Samhoedi et al.  (2004) from Gadjah Mada
University, is one of the candidates to be
developed as antiinflamatory and antican-
cer agent. This experiment was to evaluate
the effect of the curcumin’s analogue on the
cell cycle progression.
Figure 1. Curcumin and its analogues
pentagamavunon (PGV) pharmacophore division.
Part A and C, both are aromatic ring, which could be
heteroaromatic, symmetrical or not symmetrical. Part
B of the structure is b-diketone group, which has –
CH2- active methylene group responsible to the
curcumin instabilization (PGV-1: R1=R3= H) (Robinson,
2003).
Suppresion of the cell proliferation has
been related to the biological activity of the
protein p53. This protein elicits tumor sup-
pression activity by inducing cell cycle ar-
rest and apoptosis (Somasundaram and
Deiry, 2000; Volgelstein et al., 2000). Muta-
tions of p53 gene induce the tumorigenesis.
T47D cells has been reported for the mis-
sense mutation at the residue of 194 of p53.
This mutation causes the p53 not functional
in T47D cells, diminish or abolish the cell
cycle regulation (O’Connor et al., 1997). P21
WAF1/CIP1 is the downstream effector of
p53 that mediates both G1 and G2/M phase
arrest (Niculescu et al., 1998). P21 protein
levels can occur transcriptionally by p53
independent mechanism (Ding et al., 2001;
Sato et al., 2002).
Hyperploidy cells can be induced in
mammalian cells by inhibitor microtubule
organization (Verdoodt et al., 1999). Pro-
longed exposure to antimicrotubule drugs
(AMDs) induces cell to exit mitosis and en-
ter G1 phase without complete cell division
known as mitotic slippage (El Hajouji  et al.,
1998). Those cells undergo premature DNA
replication and form hyperploidy cells
known as endoreduplication (Di Leonardo
et al., 1997).  Biochemical features of cell
death induced by AMDs indicates abnor-
mal cdc-2/cyclin B activation and multiple
micronuclei known as mitotic catastrophe
(Okada and Mak, 2004). Normally, Cyclin
B is expressed during late S and G2 and bind
to Cdc-2. This complex then requires phos-
phorylation of T161 on Cdc-2 by Cdc-2 ac-
tivating kinase (CAK). The complex is re-
main inactive due to its inactivation by in-
hibitory phosphorylation of Cdc-2 at Threo-
nine 14 (T14) by Myt1 and Tyrosin 15 by
Wee1 (T15) (Poon et al., 1997; Weinert,
1997; Mueller et al., 1995; Parker and
Piwnica-Worms, 1992). This experiment
exhibited that curcumin analogue (PGV-1)
is able to act specifically, similar with the
AMDs action on the breast cancer cell line
(T47D). This compound induced G2/M ar-
rest, hyperploidy, increase p21 expression,
activated cdc-2 protein, and may induce
mitotic catastrope.
Materials  and Methods
Cell line and culture
T47D cells were provided by Prof. Masashi
Kawaichi (Nara Institute Science and Tech-
nology, Japan). Cells were cultured in
DMEM medium supplemented with 5% fe-
tal bovine serum (Gibco), 100U/ml penicil-
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lin and 100 µg/ml streptomycin.
Chemicals
PGV-1 and PGV-0 was synthesized and
purified at Gadjah Mada University.
Curcumin was purchased from E-Merck.
Cytotoxicity test
Cells were harvested by trypsinization and,
subsequently, collected in a 15 ml conical
tube and centrifuge at 1000 rpm for 5-10
minutes. The supernatant was discarded
and the cells were washed once with 1 ml
PBS and spinned at 1000 rpm for 5 min-
utes. The supernatant was again discarded
and medium was added up to 1 ml. Cells
were seeded onto 96 well plate (15.000 cells
in each well), and incubated for 24 hours.
The sample was added with the final con-
centration as indicated. The cells were in-
cubated for 24 hours. The medium was dis-
carded and replaced with the new one,
added with MTT (5 mg/ml) and followed
by four hours incubation. The formazan
was diluted in 10% SDS HCl (0.1%). The
result was measured using ELISA reader
(570 nm).
Flowcytometry
The harvested cells (7.5 X 105) were seeded
onto 5 cm dish and incubated for 24 h at 37
oC in 5% CO2. Cells were treated using the
sample at final concentration of PGV-1 2.5
mM and incubated for 24 h. Cells were har-
vested by trypsinization and collected in 15
ml tube, followed by centrifugation at 1500
rpm for 5 minute. The supernatant was dis-
carded and 500 µl of flow reagent was
added, followed by incubation for 2 min-
utes at room temperature. Subsequently,
RNa-se solution was added at final concen-
tration 1 mg/ml and Run FACS using Facs
Calibur and Cellquest software (Becton and
Dickinson).
Western blott analysis
Equal amount of proteins from cell lysates
were solubilized in 5X sample buffer and
electrophoresed in 10-15% sodium dodecyl
sulfate-polyacrilamide gels and transferred
to PVDF membrane. The membranes were
first incubated with either primer antibody
against p21, cdc-2, caspase-3, caspase-7,
phosporylated cdc-2 at tyrosine 15 or cleav-
age PARP (all were purchased from Cell
Signaling Technology) and then with a
horseradish peroxidase-conjugated second-
ary antibody (Cell Signaling Technology).
Enhanced chemiluminescence (ECL) system
(Amersham) was used to detect the proteins.
Results
Figure 2. (A) Cytotoxic effect of PGV-1, PGV-0 and
curcumin on T47D cells detected by MTT assay. The
absorbances of formazan converted to % viable cells
were plotted against concentrations. The IC-50s of
PGV-1, PGV-0, and curcumin were 1.74, 9,39, and 24,97
mM respectively. (B) Normal cell morphology exhib-
ited by control cells. (C) Multinucleate cell death  re-
sulting from the treatment of PGV-1 2.5 µM (arrow,
C).
Cytotoxic test showed that PGV-1 has
higher potency than the other curcumin
analogue (PGV-0) and its parent compound
curcumin. These results suggested that PGV-
1 is the best candidate of curcumin analogue
to be developed as anticancer agent with
IC50 against T47D cells 1,73 mM. The cells
morphology induced by PGV-1 showed sig-
nificant inhibition, and exhibited multi-
nucleate cell death (Figure 2.)
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Figure 3. Effect PGV-1 on cell cycle progression.
Flowcytometry analysis on T47D cells induced with
PGV-1 2,5 µM, cells became arrested rapidly at G2M
(4n DNA) after 12 h treatment (B) and cells became
hyperploidy after 24 h treatment (C) compare to the
control cells (A).
Cell cycle progression T47D cells in-
duced by PGV-1 2,5 µM
As shown in Figure 3 (A,B,C), the ma-
jority of cells became rapidly arrested at 4N
DNA after treatment for 12 hours (68,97%),
and formed polyploidy cells after 24 hours
treatment (41,00%). Sub G1 population in-
creased 4,91% at 12 h incubation and 8,41%
after 24 hours incubation.
Western blott analysis was run to find
out the proteins involved in the apoptosis
and cell cycle progression (especially in G2/
M phase). Apoptosis was indicated by
caspase-3,7 activation started at 12 hours
incubation. These results were consistent
with the cleavage of PARP as apoptosis
marker (Figure 4A). Apoptosis did not in-
volved extrinsic pathway as indicated no
caspase-8-clevage. Apoptosis also was p53-
independent pathway. There were not pro-
tein level change of Bax (Figure 4B) and
PUMA (Figure 4A). Both are  proapoptotic-
protein p53-dependent.
The p21 protein levels increased after
24 hours incubation, together with cdc-2
activation (Figure 4A). Collectively, these re-
sults clearly indicated that T47D cells growth
were inhibited by PGV-1 and apoptosis oc-
curred at the early phase of treatment. The
polyploidy (hyperploidy) formation indi-
cated that PGV-1 inhibited the T47D cells,
in which the T47D cells were unable to di-
vide themselves completely. The uncom-
pleted division was due to premature DNA
replication which was triggered by abnor-
mal cdc-2 activation and increased p21 ex-
pression.
Figure 4. Effect PGV-1 on apoptotic gene expression.
Western blot analysis from the cell lysates showing
PGV-1 induced the caspase-3/7 activation after 12 h
treatment, which was consistent with the PARP cleav-
age. This compound induced the cdc-2 activation after
24 h treatment and the p21 protein was elevated at the
same time. Together with flowcytometry data, these
result clearly indicated that PGV-1 inhibited the cells
growth and induced the apoptosis at the early time of
incubation.
Discussion
PGV-1 inhibited the T47D cells prolif-
eration with similar mechanism to AMDs,
i.e. by inducing the hyperploidy (polyp-
loidy) cell formation and cells commit to
apoptosis (Wang et al., 2000). PGV-1 also
activated the cdc-2 kinase protein, one of
the biochemical features of antimicrotubule
action on the cells (Okada and Mak, 2004).
Generaly apoptosis is related to cyto-
chrome c release from mytocondria and in-
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duce  Apaf1 and procaspase-9 complex for-
mation leading to caspase-9 activation
(Kasibhata and Tseng, 2003; Herr and
Debatin, 2001) or without clevage caspase-
9 (Stennicke et al., 1999). PGV-1 induced
apoptosis on T47D cells seems to be regard-
less on the caspase-8 pathway (Figure 4).
This result indicated that PGV-1 induce
apoptosis via intrinsic pathway.  Apoptosis
induced by PGV-1 also seems via p53-inde-
pendent pathway (Figure 4).
Previous experiment resulted AMDs
treatment induced Bcl-2
hiperphosphorylation. The phosphorylated
form causes Bcl-2 can not form heterodimer
with BAX and causes release cytcocrome c
from mithocondria and induce apoptosis by
caspases activation through p53-indepen-
dent (Blagosklonny et al;., 1997; Haldar et
al., 1996; Srivastava et al., 1998). Caspase-3
activation responsible for the Poly (ADP-ri-
bose) polymerase (PARP) clavege as the
apoptosis marker to be 89 and 24 kda pro-
tein (Kaufman et al., 1993; Nicholson et al.,
1995; Cryns and Yuan, 1998).
PGV-1 activated caspase-3/7 started at
12 h after incubation followed by PARP
cleavage (Figure 4). This result was con-
comitant with apoptosis evidence of MCF-
7 cells induced by AMD’s as shown the Bcl-
2 hiperphosphorylation at 3h after incuba-
tion (Wang et al., 1999). Similiar result also
resulted by Srivastava et al., (1998), their ex-
periment on cells treatment with AMDs re-
sulted in AMDs hyperphosphorylation of
Bcl-2 after 6h incubation followed caspase-
3 activation after 12h incubation. Those ex-
periments indicate Bcl-2 phosphorylation
initiate the apoptosis.
It is noteworthy that the roles of Bcl-2
phosphorylation in apoptosis still remain
controversial. The other experiment resulted
in contrast, Bcl-2 phosphorylation inhibit
the apoptosis process (Horiuchi et al., 1997;
Ito et al., 1997).  Bcl-2 phosphorylation in
the regulation AMDs-initiated apoptosis
apparently remains to be clarified.
Generaly Bcl-2 phosphorylation involve
kinase proteins like:  a) AMDs treatment in-
duces c-raf-1 activation and simultanously
followed by Bcl-2 phosphorylation
(Blagosklonny et al., 1996; 1997), b)
antimicrotubule agent induces PKA activa-
tion and phosphorylates Bcl-2 lead to
apoptosis. PKA activation also related to
microtubule disruption by AMDs
(Srivastava et al., 1998), c) The other path-
way involved MAP kinase. AMDs induced
apoptosis related with caspase-3 activation
by JNK/SAPK dependent or independent
Bcl-2 phosphorylation. JNK/SAPK activa-
tion via Ras pathway and apoptosis signal
regulating kinase (ASK-1). This activation
started at early phase AMD’s-induced
apoptosis (up to 16 h treatment) (Wang et
al., 1999; Chen et al., 1998; Seimiya et al.,
1997). This activation also related with mi-
crotubule disruption by AMDs.
Wee1 and Myt1 are kinase proteins that
inactivate the cdc-2 kinase protein
(Molinari, 2000). Wee1 and Myt1 are
caspase-3 substrate (Chang and Yang,
2000). Caspase-3 activation inactivate both
protein. Activation of cdc-2 kinase protein
induce the cells entry mitotic phase and
caused abberant mitotic. Previous experi-
ments with AMDs resulted in mitotic exit
by AMDs without chromosom segregation
and divided cells completly (Di Leonardo et
al., 1997; Elhajouji et al., 1998). This evidence
causes cells to have 4N DNA content and
still underogoing mitosis but not cytokine-
sis (endoreduplication) and form hyperp-
loidy (Di Leonardo et al., 1997) and may
cause mitotic catastrope incidence.
Cdc-2 activation may be trigered by the
other kinase as the AMDs treatment
consequency. Microtubule disruption also
induce mitotic checkpoint activation, which
was indicated by the elevation of p21 pro-
tein level through p53 independent, due to
p53 mutation in the T47D cells. This eleva-
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tion caused the cells blocked at G2/M phase
and become hyperploidy. This hyperploidy
cells may be the G1 like arrested cells or
mitotic catastrope that possibly become the
pathway to apoptosis of the cells.
As the conclusion of this research, PGV-
1 inhibit T47D cells proliferation by induc-
ing apoptosis and cell cycle arrest at G2/M
phase and hyperploidy cells through p21
expression. PGV-1 action may be mimic
AMDs inhibit cell proliferation.
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